Abstract
KURZROK and LIEB (1930) found that fresh human semen induced either strong relaxation or strong contraction of the human uterus. Several years later, two independent workers, GOLDBLATT (1935) and VON EULER (1936), reported that seminal fluid contained smooth muscle-contracting and vasodepressor activity. VON EULER named the activity, which appeared to be lipid in nature, “prostaglandin”. He discovered that it could be extracted from seminal fluid of several species and from ram vesicular gland (VON EULER 1936). The isolation of pure crystalline prostaglandins, from vesicular glands, was achieved in 1957 (BERGSTRÖM and SJÖVALL) and was followed by the first structure elucidations (BERSTRÖM et al. 1962). It is now known that the prostaglandins constitute a family of compounds of unique structure. These compounds are widely distributed in nature and have potent biological activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen BR, Littlewood SM (1982) Benoxaprofen:effect on cutaneous lesions in psoriasis. Br Med J Clin Res 285:1241
Amelang E, Prasad CM, Raymond RM, Grega GJ (1981) Interactions among inflammatory mediators on edema formation in the canine forelimb. Circ Res 49:298–306
Angaard E, Jonsson CE (1971) Effect of prostaglandins in lymph from scalded tissue. Acta Physiol Scand 81:440–447
Angaard E, Samuelsson B (1964) Prostaglandins and related factors 28. Metabolism of prostaglandin E1 in guinea pig lung:the structures of two metabolites. J Biol Chem 239:4087–4102
Archer CB, Juhlin L, MacDonald DM, Morley J, Page CP (1984) Synergistic interaction between leukotriene B4 (LTB4) and prostaglandin E2 (PGE2) in human skin:a delayed- onset phenomenon. Br J Clin Pharmacol 17:610
Barnett AH, Spiliopoulos AJ, Keen H (1980) Blockade of chlorpropamide-alcohol flushing by indomethacin suggests an association between prostaglandins and diabetic vascular complications. Lancet 11:164–166
Barr RM, Brain SD, Camp RDR, Cilliers J, Greaves MW, Mallett AL, Misch K (1984) Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis. Br J Dermatol 111:23–28
Basran GS, Morley J, Paul W, Turner-Warwick M (1982) Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet 1:935–937
Bergström S, Sjövall J (1957) The isolation of prostaglandin. Acta Chem Scand 11:1086
Bergstrom S, Duner H, von Euler US, Pernow B, Sjovall J (1959) Observations on the effects of infusion of prostaglandin E in man. Acta Physiol Scand 45:145–151
Bergström S, Ryhage R, Samuelsson B, Sjövall J (1962) The structure of prostaglandin E, F1, and F2. Acta Chem Scand 16:501–502
Bergström S, Danielsson H, Samuelsson B (1964) The enzymatic conversion of essential fatty acids into prostaglandins. J Biol Chem 239:4006–4008
Bisgaard H, Kristensen J, Sondergaard J (1982) The effect of leukotriene C4 and D4 on cutaneous blood flow in humans. Prostaglandins 23:797–801
Black AK, Greaves MW, Hensby CN, Plummer NA, Warin AP (1978) The effects of indomethacin on arachidonic acid and prostaglandins E2 and F2 levels in human skin 24 h after u.v.B. and u.v.C. irradiation. Br J Clin Pharmacol 6:261–266
Black AK, Fincham N, Greaves MW, Hensby CN (1980) Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 10:453–157
Blackwell GJ, Flower RJ, Nijkamp FP, Vane JR (1978) Phospholipase A2 activity of guinea-pig isolated perfused lungs:stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol 62:79–89
Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Parente L, Persico P (1980) Macrocortin:a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287:147–149
Boot JR, Dawson W, Kitchen EA (1976) The chemotactic activity of thromboxane B2:a possible role in inflammation. J Physiol (Lond) 257:47
Borgeat P, Samuelsson B (1979 a) Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. J Biol Chem 254:2643–2646
Borgeat P, Samuelsson B (1979 b) Metabolism of arachidonic acid in polymorphonuclear leukoeytes. J Biol Chem 254:7865–7869
Borgeat P, Samuelsson B (1979 c) Arachidonic acid metabolism in polymorphonuclear leukocytes: effect of calcium ionophore A23187. Proc Natl Acad Sci USA 76:2148–2152
Brain SD, Camp RDR, Dowd PM, Black AK, Woollard PM, Mallet Al, Greaves MW (1982 a) Psoriasis and leukotriene B. Lancet 11:762–763
Brain SD, Camp RDR, Leigh IM, Fort-Hutchinson AW (1982 b) The synthesis of leukotriene B4-like material by cultured human keratinocytes. J Invest Dermatol 78:328
Brain SD, Camp RDR, Charleson S, Dowd PM, Ford-Hutchinson AW, Greaves MW, Kobza Black A (1984) The release of LTC4-like material from the involved lesional skin in psoriasis. Br J Clin Pharmacol 17:650
Bray MA (1983) The pharmacology and pathophysiology of leukotriene B4. Br Med Bull 39:249–254
Bray MA, Cunningham FM, Ford-Hutchinson AW, Smith MJH (1981 a) Leukotriene B4: a mediator of vascular permeability. Br J Pharmacol 72:483–486
Bray MA, Ford-Hutchinson AW, Smith MJH (1981b) Leukotriene B4:biosynthesis an biological activities. In:Piper PJ (ed) SRS-A and leukotrienes. Wiley, London
Bray MA, Ford-Hutchinson AW, Smith MJH (1981 c) Leukotriene B4: an inflammatory mediator in vivo. Prostaglandins 22:213–222
Brocklehurst WE (1967) The probable role of known mediators in hypersensibility reactions. In:Schild HO (ed) Proceedings of the 3rd International Pharmacological Meeting, vol II. Pergamon, Oxford, pp 67–75
Camp RDR, Coutts AA, Greaves MW, Kay AB, Walport MJ (1983a) Responses of human skin to intradermal injection of leukotrienes C4, D4, and B4. Br J Pharmacol 80:497–502
Camp RDR, Mallet Al, Woollard PM, Brain SD, Kobza Black A, Greaves MW (1983 b) The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins 26:431–448
Camp RDR, Russell Jones R, Brain S, Woollard P, Greaves MW (1984) Production of in- traepidermal microabscesses by topical application of leukotriene B4. J Invest Dermatol 82:202–204
Cashin CH, Dawson W, Kitchen EA (1977) The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol 29:330–336
Crawford JP, Movat HZ, Ranadive NS, Hay JB (1982) Pathways to inflammation induced by immune complexes:development of the Arthus reaction. Fed Proc 41:2583–2587
Crunkhorn P, Willis AL (1969) Actions and interactions of prostaglandins administered intradermally in rat and man. Br J Pharmacol 36:216
Crunkhorn P, Willis AL (1971) Interaction between prostaglandins E and F given intradermally in the rat. Br J Pharmacol 41:507–512
Cunningham FM, Carter HR, Smith MJH, Ford-Hutchinson AW, Bray MA (1981) Aggregation of polymorphonuclear leucocytes (PMNs) by leukotriene B4:effects of cyclooxygenase products and metabolic inhibitors. Agents Actions 11:583–584
Danon A, Assonline G (1978) Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis. Nature 273:552–554
Dawson W, Boot JR, Harvey J et al. (1982) The pharmacology of benoxaprofen with particular reference to effects on lipoxygenase product formation. Eur J Rheumatol Inflamm 5:61–68
Dowd PM, Kobza Black A, Woollard P, Camp RDR, Greaves MW (1984) The in vivo properties of 12-hydroxyeicosatetraenoic acid (12-HETE) in normal skin. J Invest Dermatol 82:413–414 (abstract)
Drazen JM, Austen KP, Lewis RA, Clark DA, Goto G, Marfat A, Corey EJ (1980) Comparative airway and vascular activities of leukotrienes C-l and D in vivo and in vitro. Proc Natl Acad Sci USA 77:4354–4358
Dusting GJ, Moncada S, Vane JR (1978) Vascular actions of arachidonic acid and its metabolites in the perfused mesenteric and femoral beds of the dog. Eur J Pharmacol 49:65–72
Fantone JC, Marasco WA, Eglas LJ, Ward PA (1983) Anti-inflammatory effects of prostaglandin Ex:in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. J Immunol 130:1495–1497
Ferreira SH (1972) Prostaglandins, aspirin-like drugs and analgesia. Nature New Biol 240:200–203
Ferreira SH, Moncada S, Vane JR (1971) Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol 231:237–239
Ferreira SH, Nakamura M, Abreu Castro MS (1978) The hyperalgesic effects of prostacyclin and PGE2. Prostaglandins 16:31–37
Flower RJ (1974) Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26:33–67
Flower RJ (1978) Steroidal anti-inflammatory drugs as inhibitors of phospholipase A2. Adv Prostaglandin and Thromboxane Leukotriene Res 3:105–112
Flower RJ, Blackwell GJ (1979) Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456–459
Flower RJ, Harvey EA, Kingston WP (1976) Inflammatory effects of prostaglandin D2 in rat and human skin. Br J Pharmacol 56:229–233
Ford-Hutchinson AW, Smith AW, Walker JR (1976) Chemotactic activity of solutions of prostaglandin E1. Br J Pharmacol 56:345
Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH (1980) Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265
Ford-Hutchinson AW, Bray MA, Cunningham FM, Davidson EM, Smith MJH (1981) Isomers of LTB4 possess different biological potencies. Prostaglandins 21:143
Goetzl EJ, Pickett WC (1980) The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J Immunol 125:1789–1791
Goetzl EJ, Sun FF (1979) Generation of unique monohydroxy-eicosatetraenoic acids from arachidonic acid by neutrophils. J Exp Med 150:406–411
Goetzl EJ, Woods JMW, Gorman RR (1977) Stimulation of human eosinophil and neutrophil PMN chemotaxis and random migration by 12-HETE. J Clin Invest 59:179–183
Goetzl EJ, Weller PE, Sun FF (1980) The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J Immunol 124:926–933
Goldblatt MW (1935) Properties of humans seminal fluid. J Physiol (Lond) 84:208–218
Grabbe J, Czarnetzki BM, Mardin M (1982) Chemotactic leukotrienes in psoriasis. Lancet 11:1464
Greaves MW, Sondergaard J, McDonald-Gibson W (1971) Recovery of prostaglandins in human cutaneous inflammation. Br Med J [Clin Res] 2:258–260
Gryglewski RJ, Panczenko B, Korbut R, Grodzinska L, Ocetkiewicz A (1975) Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitised guinea-pig. Prostaglandins 5:531–542
Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformation of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71:3400–3404
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxane:a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994–2998
Hammerström S, Hamberg M, Samuelsson B, Duell EA, Stawiski M, Voorhees JJ (1975) Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2 in epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130–5134
Hammerström S, Hamberg M, Duell EA et al. (1977) Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids. Science 197:994–995
Hammerström S, Lindgren JA, Marcelo C, Duell EA, Anderson TF, Voorhees JJ (1979) Arachidonic acid transformation in normal and psoriatic skin. J Invest Dermatol 73:180–183
Higgs EA, Moncada S, Vane JR (1978a) Inflammatory effects of prostacyclin (PGI2) and 6-oxo PGF1α in the rat paw. Prostaglandins 16:153–162
Higgs EA, O’Grady J, Thrower PA, Moncada S (1979) Prostacyclin: inflammatory effects in human skin. Fourth international prostaglandin conference, May 1979, Washington DC, meeting abstracts, p 48
Higgs GA, McCall E, Youlten LJF (1975) A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis. Br J Pharmacol 53:539–546
Higgs GA, Moncada S, Vane JR (1978 b) Prostacyclin (PGI2) as a potent dilator of arterioles in the hamster cheek pouch. J Physiol (Lond) 526:43
Higgs GA, Salmon JA, Spayne JA (1981) The inflammatory effects of hydroperoxy and hydroxy acid products of arachidonate lipoxygenase in rabbit skin. Br J Pharmacol 74:429–433
Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 77:2533–2536
Horton EW (1963) Action of prostaglandin E1 on tissues which respond to bradykinin. Nature 200:892–893
Johnson RA, Morton DR, Kinner JH, Corman RR, McGuire JR, Sun FF, Whittaker N, Bunting S, Salmon J, Moncada S, Vane JR (1976) The chemical characterization of prostaglandin X (prostacyclin). Prostaglandins 12:915–928
Jonsson DC, Angaard E (1972) Biosynthesis and metabolism of prostaglandin E2 in human skin. Scand J Clin Lab Invest 29:289–296
Jose PJ, Forrest MJ, Williams TJ (1981) Human C5a des Arg increases vascular permeability. J Immunol 127:2376–2380
Juhlin S, Michaelsson G (1969) Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol (Stockh) 49:251–261
Kaley G, Weiner R (1968) Microcirculatory studies with prostaglandin E1 In:Ramwell PW, Shaw JE (eds) Prostaglandin symposium of the Worcester foundation for experimental biology. Interscience, New York, pp 321–328
Katayama H, Kawada A (1981) Exacerbation of psoriasis induced by indomethacin. J Dermatol 8:323–337
Kingston T, Marks R (1982) Benoxaprofen:effect on cutaneous lesions in psoriasis. Br Med J [Clin Res] 285:1741
Kligman AM, Kaidbey KH (1982) Phototoxicity to benoxaprofen. Eur J Rheumatol Inflamm 5:124–137
Kobza Black A, Greaves MW, Hensby CN, Plummer NA (1978) Increased prostaglandins E2 and F2 in human skin 6 and 24 h after ultraviolet B irradiation (290–320 nm). Br J Clin Pharmacol 5:431–436
Kobza Black A, Greaves MW, Hensby CN (1982) The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 levels in human cutaneous inflammation. Br J Clin Pharmacol 14:391–394
Komoriya K, Ohmori H, Azuma A, Kurozumi S, Hashimoto Y, Nicolaou KC, Barnette WF, Mangolda RL (1978) Prostaglandins 15:557–564
Kopaniak MM, Hay JB, Movat HZ (1978) The effect of hyperemia on vascular permeability. Microvasc Res 15:77–82
Kragballe K, Herlin T (1983) Benoxaprofen improves psoriasis:a double blind study. Arch Dermatol 119:548–552
Kurzrok R, Lieb CC (1930) Biochemical studies of human semen. II. The action of semen on the human uterus. Proc Soc Exp Biol Med 28:268–272
Lewis AJ, Nelson DJ, Sugrue MF (1975) On the ability of prostaglandin and arachidonic acid to modulate experimentally induced oedema in rat paw. Br J Pharmacol 55:51–56
Lewis GP, Westwick J, Williams TJ (1977) Microvascular responses produced by the prostaglandin endoperoxide PGG2 in vivo. Br J Pharmacol 59:442
Malik KU, McGiff JC (1976) Cardiovascular actions of prostaglandins. In:Karim SMM (ed) Prostaglandins:physiological, pharmacological and pathological aspects. MTP Press, Lancaster, pp 103–200
Moncada S, Ferreira SH, Vane JR (1973) Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature 246:217–219
Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665
Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M, Samuelsson B (1976) Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature 261:558–560
Nugteren DH (1975) Arachidonate lipoxygenase in blood platelets. Biochim Biophys Acta 380:299–307
O’Flaherty JT, Kreutzer DL, Ward PA (1979) Effect of prostaglandins E1, E2, and F2 on neutrophil aggregation. Prostaglandins 17 (2):201–210
O’Flaherty JT, Thomas MH, Less CJ, McCall CE (1981) Neutrophil aggregating activity of monohydroxy-eicosatetraenoic acids. Am J Pathol 104:55–62
Palmer RMJ, Stepney RJ, Higgs GA, Eakins K (1980) Chemokinetic activity of arachidonic acid lipoxygenase products on leucocytes of different species. Prostaglandins 20:411–418
Peck MJ, Williams TJ (1978) Prostacyclin (PGI2) potentiates bradykinin-induced plasma exudation in rabbit skin. Br J Pharmacol 62:464–465 P
Peck MJ, Piper PJ, Williams TJ (1981) The effect of leukotrienes C4 and D4 on the micro-vasculature of guinea-pig skin. Prostaglandins 21:315–321
Phillips WS, Lightman SL (1981) Is cutaneous flushing prostaglandin mediated? Lancet 1:754–756
Piper PJ (1983) Pharmacology of leukotrienes. Br Med Bull 39:255–259
Piper PJ, Vane JR (1969) Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 223:29–35
Rome LH, Lands WFM (1975) Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc Natl Acad Sci USA 72:4863–4865
Ruzicka T, Printz MP (1982) Arachidonic acid metabolism in guinea-pig skin. Biochim Biophys Acta 711:391–397
Ruzicka T, Simmer T, Peskar BA, Braun Falco O (1984) Leukotrienes in skin of atopic dermatitis. Lancet I:222
Shen TY (1979) Prostaglandin synthetase inhibitors I. Handb Exp Pharmacol 50/11:305–347
Sirois P, Roy S, Borgeat P, Picard S, Corey EJ (1981) Structural requirement for the action of leukotriene B4 on the guinea-pig lung:importance of double bond geometry in the 6,8,10-triene unit. Biochem Biophys Res Commun 99:385–390
Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature New Biol 321:235–237
Solomon LM, Juhlin L, Kirschbaum MM (1968) Prostaglandins on cutaneous vasculature. J Invest Dermatol 51:280–282
Sondergaard J, Greaves MW (1970) Pharmacological studies in inflammation due to ultraviolet radiation. J Pathol 101:93–97
Sondergaard J, Greaves MW (1971) Prostaglandin E1:effect on human cutaneous vasculature and skin histamine. Br J Dermatol 84:424
Sondergaard J, Greaves MW, Jorgenson HP (1974) Recovery of prostaglandins in human primary irritant dermatitis. Arch Dermatol 110:556–558
Soter NA, Lewis RA, Corey EJ, Austen KF (1983) Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin. J Invest Dermatol 80:115–119
Strakosch CR, Jefferys DB, Keen H (1980) Blockade of chlorpropamide alcohol flush by aspirin. Lancet 1:394–396
Thomas G, West GB (1973) Prostaglandins as modulators of bradykinin responses. J Pharm Pharmacol 25:747–748
Turner SR, Campbell JA, Lynn WS (1975a) Polymorphonuclear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J Exp Med 141:1437–1441
Turner SR, Tainer JA, Lynn WS (1975 b) Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature 257:680–681
Vadas P, Hay JB (1982) The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions. Am J Pathol 107:285–291
Vadas P, Wasi S, Movat HZ, Hay JB (1981) Extracellular phospholipase A2 mediates inflammatory hyperaemia. Nature 293:583–585
Van Dorp DA, Beerthuis RK, Nugteren DH, Vonkeman H (1964) The biosynthesis of prostaglandins. Biochim Biophys Acta 90:204–207
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs. Nature 231:232–235
Von Euler US (1936) On the specific vasodilating and plain muscle stimulating substance from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol (Lond) 88:213–234
Wedmore CV, Williams TJ (1981) Control of vascular permeability by polymorphonuclear leucocytes in inflammation. Nature 289:646–650
Williams TJ (1979) Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol 65:517–524
Williams TJ (1982) Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol 77:505–509
Williams TJ (1983) Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br Med Bull 39:239–242
Williams TJ, Jose PJ (1981) Mediation of increased vascular permeability after complement activation:histamine-independent action of rabbit C5a. J Exp Med 153:136–153
Williams TJ, Morley J (1973) Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246:215–217
Williams TJ, Peck MJ (1977) Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270:530–532
Williams TJ, Piper PJ (1980) The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins 19:779–789
Ziboh VA, Marcelo CL, Voorhees JJ (1981) Induced lipoxygenation of arachidonic acid in mouse epidermal keratinocytes by calcium ionophore A23187, abstracted. J Invest Dermatol 76:307
Ziboh VA, Mallia C, Morhart E, Taylor JR (1982) Induced biosynthesis of cutaneous prostaglandins by ionizing irradiation (41362). Proc Soc Exp Biol Med 169:386–391
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Brain, S.D., Williams, T.J. (1989). Prostaglandins, Leukotrienes, Related Compounds and Their Inhibitors. In: Greaves, M.W., Shuster, S. (eds) Pharmacology of the Skin I. Handbook of Experimental Pharmacology, vol 87 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73797-8_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-73797-8_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73799-2
Online ISBN: 978-3-642-73797-8
eBook Packages: Springer Book Archive